Published in Nucl Med Commun on April 01, 1992
Informed consent. BMJ (1993) 0.75
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Atomic structure of graphene on SiO2. Nano Lett (2007) 4.59
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea. Lancet (1968) 3.78
Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol (1966) 2.99
Prostaglandins in amine-peptide-secreting tumours. Lancet (1968) 2.75
Radionuclide migration through the genital tract in infertile women with endometriosis. Hum Reprod (1993) 2.67
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer (1979) 2.67
Distribution of prostaglandins in human tissues. Br J Pharmacol Chemother (1967) 2.58
The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer (1989) 2.52
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry. Nature (1988) 2.28
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene (1989) 1.98
A simple post-embedding system for the rapid demonstration of tissue antigens under the electron microscope. Histochem J (1983) 1.95
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol (1998) 1.92
Age related reactivation of an X-linked gene. Nature (1987) 1.92
Pathology of 'nonendocrine' tumors associated with Cushing's syndrome. Cancer (1968) 1.85
Tumurs, hormones, and cellular differentiation. Lancet (1969) 1.75
Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's disease. J Pathol Bacteriol (1966) 1.74
A comparison of two methods for measuring the signal to noise ratio on MR images. Phys Med Biol (1999) 1.71
Multiple forms of human brain mitochondrial monoamine oxidase. Nature (1970) 1.69
Use of yttrium 90 in persistent synovitis of the knee. I. Retention in the knee and spread in the body after injection. Ann Rheum Dis (1973) 1.66
Racial variation in the O-acetylation phenotype of human colonic mucosa. J Pathol (1994) 1.62
Chloroquine-resistant falciparum malaria among British service personnel in West Malaysia and Singapore. Trans R Soc Trop Med Hyg (1971) 1.60
Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol (1966) 1.57
Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology (1994) 1.53
Thyroid function tests are rarely abnormal in patients with severe hyperemesis gravidarum. Clin Endocrinol (Oxf) (1992) 1.48
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage (2002) 1.44
Pressure exerted by head bandages used in otological surgery. J Laryngol Otol (1993) 1.39
Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry (1987) 1.39
Training of staff for the delivery of PET/CT services in the UK. Nucl Med Commun (2006) 1.39
Exchange of nuclear medicine image files. Nucl Med Commun (1990) 1.38
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab (1999) 1.37
Defect scattering in graphene. Phys Rev Lett (2009) 1.37
Concurrent estimation of total body and exchangeable body sodium in hypertension. Clin Sci Mol Med (1978) 1.34
The demonstration of tissue clonality by X-linked enzyme histochemistry. J Pathol (1988) 1.33
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology (2001) 1.32
Thymic and parathyroid origin of calcitonin in man. Lancet (1968) 1.31
Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol (1991) 1.30
Calcitonin receptor antibodies in the identification of osteoclasts. Bone (1999) 1.29
Thyroid cancer in an iodide rich area: a histopathological study. Cancer (1977) 1.28
Crypt restricted heterogeneity of goblet cell mucus glycoprotein in histologically normal human colonic mucosa: a potential marker of somatic mutation. Br J Cancer (1990) 1.25
Value of external quality assessment of the technical aspects of histopathology. J Clin Pathol (1982) 1.24
Tuning the effective fine structure constant in graphene: opposing effects of dielectric screening on short- and long-range potential scattering. Phys Rev Lett (2008) 1.22
Fatal retroperitoneal haemorrhage complicating anticoagulant therapy. Postgrad Med J (1979) 1.21
A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. Br J Radiol (1984) 1.21
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Oncogene (1991) 1.20
Calibration and evaluation of a system of total body in vivo activation analysis using 14 MeV neutrons. Phys Med Biol (1978) 1.20
High-fidelity conformation of graphene to SiO2 topographic features. Phys Rev Lett (2010) 1.19
The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology (1983) 1.19
Automated histoquantitation studies of bone. Proc R Soc Med (1972) 1.19
Whole body elemental composition during drug treatment of rheumatoid arthritis: a preliminary study. Ann Rheum Dis (1979) 1.18
Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet (1986) 1.17
Physical randomization of tissue architecture: an alternative to systemic sampling. J Microsc (1982) 1.17
The Chernobyl thyroid cancer experience: pathology. Clin Oncol (R Coll Radiol) (2011) 1.17
Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol Carcinog (2000) 1.16
Use of yttrium 90 in persistent synovitis of the knee. II. Direct comparison of yttrium colloid resin and yttrium citrate. Ann Rheum Dis (1974) 1.16
Antioxidants: their role in pregnancy and miscarriage. Antioxid Redox Signal (2000) 1.16
Quality assurance for MRI: practical experience. Br J Radiol (2000) 1.14
Post-irradiation somatic mutation and clonal stabilisation time in the human colon. Gut (1996) 1.13
Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol (1996) 1.11
Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. J Nucl Med (1985) 1.11
Control of human thyroid follicular cell proliferation in suspension and monolayer culture. Mol Cell Endocrinol (1987) 1.11
Thyroid carcinoma and Cushing's syndrome. A report of two cases with a review of the common features of the "non-endocrine" tumours associated with Cushing's syndrome. J Clin Pathol (1968) 1.10
Use of monoclonal antihapten antibodies for immunolocalisation of tissue antigens. J Clin Pathol (1981) 1.09
Ha-ras restriction fragment length polymorphisms in colorectal cancer. Br J Cancer (1988) 1.09
Parathyroid carcinoma in familial hyperparathyroidism. J Clin Pathol (1977) 1.08
The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. Cancer (1981) 1.08
Gonadal dysgenesis and ulcerative colitis. A case report with clinical, cytogenetic, and post-mortem studies. J Med Genet (1966) 1.08
Diarrhoea and thyroid carcinoma. Proc R Soc Med (1966) 1.08
Cytomegalic inclusion disease in the adult. J Clin Pathol (1968) 1.08
The clonal origin of experimental large bowel tumours. Br J Cancer (1989) 1.08
Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J (1983) 1.07
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. Br J Cancer (1991) 1.07
Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg (1990) 1.07
Childhood thyroid cancer in England and Wales. Br J Cancer (1995) 1.07
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases. Br J Cancer (1988) 1.05
Studies of splenic function in the myeloproliferative disorders and generalized malignant lymphomas. Br J Haematol (1971) 1.05
Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement? Br Med J (Clin Res Ed) (1986) 1.05
The distribution and dosimetry of 111-IN-bleomycin in man. Br J Radiol (1975) 1.05
Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension. Br J Clin Pharmacol (1976) 1.04
Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation. Eur J Cancer (1994) 1.04
Thermodynamics of surface morphology. Science (1991) 1.04
Thyroid epithelial cell transformation by a retroviral vector expressing SV40 large T. Br J Cancer (1989) 1.03
Studies of thyroid function using 99Tcm in thyrotoxic patients during treatment with antithyroid drugs. Clin Endocrinol (Oxf) (1973) 1.03
Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol (Copenh) (1985) 1.03
Measurement of splenic red cell volume and visualization of the spleen with 99mTc. J Nucl Med (1973) 1.03
Management of selected patients with hyperprolactinaemia by partial hypophysectomy. Br Med J (Clin Res Ed) (1985) 1.03
The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol (Oxf) (1991) 1.02
Distribution of yttrium 90 ferric hydroxide colloid and gold 198 colloid after injection into knee. Ann Rheum Dis (1976) 1.02
The clonal origin of thyroid nodules and adenomas. Am J Pathol (1989) 1.02
Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. Nucl Med Commun (1987) 1.02
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Br J Cancer (2008) 1.02
Multiple endocrine neoplasia associated with von Recklinghausen's disease. Br Med J (Clin Res Ed) (1983) 1.02
Evaluation of thallium-201 exercise scintigraphy in coronary heart disease. Br Heart J (1979) 1.01
Estimation of pituitary gland dimensions from radiographs of the sella turcica. A post-mortem study. Br J Radiol (1968) 1.01
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01
Thyroid tumor banks. Science (2000) 1.00